Pioneer in phage-based diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Phage-based diagnostics
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations
Menu
  • Home
  • About
    • About PBD Biotech
    • Leadership
    • Blog
  • Latest
    • Press releases
    • In the news
    • Events
  • Actiphage TB
    • What is Actiphage TB?
    • Phage-based diagnostics
    • Unique role in TB testing
    • Supporting test and treat campaigns
    • Clinical studies
  • Lab Support
    • Laboratory Support
    • Solutions for laboratory developed tests
    • Actiphage assay workflow
    • Instructions for use of Actiphage
  • TB Drug Research
    • TB drug research
    • Research Use Only
    • Biomarker for TB prevention
  • Contact
    • Contacting us
    • Partnerships and collaborations

Actiphage® TB diagnostic to start R2D2 TB Network lab-side assessment

PBD Biotech has been working closely with the R2D2 TB Network to set up the trial protocol for its Actiphage® tuberculosis diagnostic, and the first test kit is being dispatched.
  • October 27, 2023
  • Actiphage, Human health, International, Latest
  • human TB, R2D2 TB Network
R2D2 TB Network logo

The Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) is funded by the US National Institutes of Health and offers clinical evaluation of a TB diagnostic to validate its accuracy and ensure that it is practical for use in the field.

Actiphage is a phage-based diagnostic that can detect active TB disease from a sample of blood. It is to be assessed at a clinical site in the Philippines where patients are being treated for TB. The trials are to see how easy it is to use in a public health laboratory.

The R2D2 TB Network is ideally placed to provide this analysis. It has an extensive network of clinical trial sites, including in Asia (India, Vietnam, the Philippines), Africa (Uganda, South Africa), and Eastern Europe (Georgia), with extensive TB and respiratory disease expertise.

Jane Theaker, CEO of PBD Biotech, says the support of the R2D2 TB Network is invaluable.

“Although TB is a risk worldwide it is particularly prevalent in lower income communities. We want to ensure that Actiphage can fit within current workflows and that the instructions for use are clear and easy to follow in the field.

“R2D2 TB Network provides an independent and transparent process for the assessment of promising TB diagnostics, and we welcome their expertise and feedback.”

The Actiphage kit enables testing of up to 100 people. It will be used to identify viable Mycobacterium tuberculosis (Mtb) in samples of blood from patients attending a clinic for those with suspected TB, but it will not provide a clinical diagnosis. The patients will be assessed and treated according to current protocols.

Adithya Cattamanchi, one of the principal investigators involved with the R2D2 TB Network, comments: “Improved diagnostics for TB are urgently required, especially for children, so we are pleased to be evaluating a novel diagnostic in the community where it is most needed.”

PBD Biotech is one of the diagnostic developers listed on the R2D2 TB Network website, but Actiphage is the only blood test to directly detect live Mycobacterium tuberculosis in the blood.

Share:

Related posts

Loading...
Leicester Respiratory Biomedical Research Unit

Actiphage TB enters third clinical trial

July 6, 2023
Actiphage TB is to enter its third clinical trial, which is aimed at validating its utility as a tuberculosis diagnostic. The phage-based diagnostic has potential for detecting TB progression.
Leicester Respiratory Biomedical Research Unit

Actiphage TB enters third clinical trial

July 6, 2023
Actiphage TB is to enter its third clinical trial, which is aimed at validating its utility as a tuberculosis diagnostic....
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
pan North West of England’s Health and Life Sciences Cluster fight-against-infectious-disease

Phage-based diagnostics and the fight against infectious disease

May 22, 2023
PBD Biotech to speak at Liverpool School of Tropical Medicine anniversary celebrations
AACC webinar phage-based TB diagnostics

PBD Biotech announces AACC webinar to support awareness of new TB diagnostics

March 23, 2023
We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic tests that are urgently needed to screen LTBI and determine who will progress to active TB disease.
AACC webinar phage-based TB diagnostics

PBD Biotech announces AACC webinar to support awareness of new TB diagnostics

March 23, 2023
We embrace the World TB day theme 'Yes! We Can End TB' with an educational webinar event on new diagnostic...
global unmet need for rapid molecular diagnostic for human TB

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023
PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis (TB) and will be suspending its commercial Johne’s Testing Service.
global unmet need for rapid molecular diagnostic for human TB

Targeting global unmet need for rapid molecular diagnostic for human TB

January 19, 2023
PBD Biotech is announcing that is focusing its efforts on developing Actiphage as a rapid blood test for Human Tuberculosis...
1 2 3 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

BIVDA member 2023
Twitter Youtube Linkedin

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house